StockData
MediWound Ltd. logo

MediWound Ltd. (MDWD) stock

MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$13.55+0.65 (+5.04%)

Close on Nov 16, 2026Market cap $173.92MP/E –Yield –

MediWound price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

MediWound's price to sales ratio was 10.7× on Nov 10, 2026, against 11.4× a year earlier. Over the last 5 years it ranged from 1.9× to 11.7×, with a median of 8.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 202610.7×−1.0
2025Dec 31, 202511.7×+2.9
2024Dec 31, 20248.8×+5.3
2023Dec 29, 20233.5×+0.8
2022Dec 30, 20222.7×−0.3
2021Dec 31, 20213.0×−0.2
2020Dec 31, 20203.2×−21.6
2019Dec 31, 201924.8×−19.4
2018Dec 31, 201844.2×−18.5
2017Dec 29, 201762.7×−102.8
2016Dec 30, 2016165.5×–

More MediWound figures

See a number that looks wrong?